Teva Pharmaceutical Industries Limited（TEVA）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · TEVA · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2023-12	2022-12	2021-12
Revenue
Revenue	$17.26B	$16.54B	$15.85B	$14.93B	$15.88B
Cost of Revenue	$8.32B	$8.48B	$8.20B	$7.95B	$8.28B
Gross Profit	$8.94B	$8.06B	$7.64B	$6.97B	$7.59B
Gross Margin %(computed)	51.79%	48.74%	48.25%	46.72%	47.83%
Operating Expenses
R&D Expenses	$1.01B	$1.05B	$0.95B	$0.84B	$1.09B
G&A Expenses	$1.29B	$1.16B	$1.16B	$1.18B	$1.10B
Total Operating Expenses	$6.78B	$8.37B	$7.21B	$9.17B	$5.88B
Operating Income	$2.16B	($0.30B)	$0.43B	($2.20B)	$1.72B
Operating Margin %(computed)	12.50%	-1.83%	2.73%	-14.72%	10.81%
Interest Income	$0.00B	$0.00B	$0.07B	$0.00B	$0.00B
Interest Expense	$0.92B	$0.94B	$1.03B	$0.93B	$0.89B
Income Before Tax	$1.24B	($1.28B)	($0.62B)	($3.14B)	$0.67B
Income Tax Expense	($0.18B)	$0.68B	($0.01B)	($0.64B)	$0.21B
Net Income	$1.41B	($1.64B)	($0.56B)	($2.45B)	$0.42B
Net Margin %(computed)	8.17%	-9.91%	-3.53%	-16.39%	2.63%
Per Share & EBITDA
EPS (Basic)	$1.23	$-1.45	$-0.50	$-2.20	$0.38
Wtd Avg Shares	1.15B	1.13B	1.12B	1.11B	1.10B
EBITDA	$3.14B	$4.43B	$1.56B	($0.93B)	$4.41B
EBITDA Margin %(computed)	18.20%	26.78%	9.83%	-6.20%	27.77%